Neostem (NBS)

Add to Watchlists
Create an Alert
6.66 +0.23  +3.58% NASDAQ Apr 16, 5:00PM BATS Real time Currency in USD
View Full Chart
NBS Price Chart
View All Events

NBS Events

Date Type Description
Oct 28 Dividends Amount: 0.31, Declared Date: Sep 21 2013, Pay Date: Nov 22 2013
Oct 03 Misc AGM Event for Neostem Inc
Jul 16 Splits Ratio: 3602879701896397:36028797018963968
View All Performance Charts

NBS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Neostem is up 1.39% over the last year vs S&P 500 Total Return up 22.52%, ANI Pharmaceuticals up 256.5%, and Trevena up N/A.

Get Quote for

Pro Strategies Featuring NBS

Did Neostem make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

NBS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Neostem, Inc., is an international biopharmaceutical company. It operates in three reportable segments namely Cell Therapy-United States; Regenerative Medicine-China; and Pharmaceutical Manufacturing-Manufacturing.

Recent Quotes

Symbol Price Chg Chg % Market Cap
NBS 6.66 +0.23 +3.58% 181.13M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.